Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
national blog main
new york blog main
6
×
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
deals
eli lilly
fda
sanofi
bristol-myers squibb
cancer
ipo
startups
takeda pharmaceutical
abeona therapeutics
affordable care act
agios pharmaceuticals
alexion pharmaceuticals
What
bio
6
×
pharmaceutical
6
×
roundup
american
based
best
cancer
companies
continue
crash
debate
drugs
hasn’t
healthcare
industry
kind
latest
nash
new
people
policy
politicians
pressure
scalps
trump’s
typically
u.s
alzheimer’s
appetite
bails
bets
black
brand
bread
bridgebio
butter
buyout
capital
car
cash
Language
unset
Current search:
pharmaceutical
×
" new york blog main "
×
bio
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines